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Psychological interventions for chronic pain and its consequences have been shown to improve 
mood, disability, pain, and catastrophic thinking, but there has been no systematic review 
specifically of their effects on health care use or time lost from work as treatment outcomes in 
mixed chronic pain. We conducted a systematic review and meta-analysis to evaluate the 
effectiveness of psychological therapies for chronic pain (excluding headache) in adults for these 
outcomes. We used searches from two previous systematic reviews and updated them. Eighteen 
randomized controlled trials were found that reported health care use (15 studies) and work loss 
(nine studies) as outcomes. Fourteen studies provided data for meta-analysis. There were moderate 
effects for psychological interventions compared to active, treatment as usual and waiting list 
controls in reducing health care use, with confidence in the findings. No benefits were found for 
medication reduction, but with less confidence in this result. Analysis of work loss showed no 
significant effects of psychological interventions over comparisons, but the use of many different 
metrics necessitated fragmenting the planned analyses, making summary difficult. The results are 
encouraging for the potential of routine psychological intervention to reduce post-treatment health 
care use, with associated cost savings, but it is likely that the range and complexity of problems 
affecting work necessitate additional intervention over standard group psychological intervention.  
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Abstract 
Psychological interventions for chronic pain and its consequences have been shown to improve mood, 
disability, pain, and catastrophic thinking, but there has been no systematic review specifically of their 
effects on health care use or time lost from work as treatment outcomes in mixed chronic pain. We 
conducted a systematic review and meta-analysis to evaluate the effectiveness of psychological 
therapies for chronic pain (excluding headache) in adults for these outcomes. We used searches from 
two previous systematic reviews and updated them. Eighteen randomized controlled trials were found 
that reported health care use (15 studies) and work loss (nine studies) as outcomes. Fourteen studies 
provided data for meta-analysis. There were moderate effects for psychological interventions compared 
to active, treatment as usual and waiting list controls in reducing health care use, with confidence in the 
findings. No benefits were found for medication reduction, but with less confidence in this result. 
Analysis of work loss showed no significant effects of psychological interventions over comparisons, but 
the use of many different metrics necessitated fragmenting the planned analyses, making summary 
difficult. The results are encouraging for the potential of routine psychological intervention to reduce 
post-treatment health care use, with associated cost savings, but it is likely that the range and 
complexity of problems affecting work necessitate additional intervention over standard group 
psychological intervention.  
Keywords: rehabilitation; CBT; medication; hospital visits; work loss. 
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1. Introduction 
Systematic review and meta-analysis of cognitive and behavioral (CBT) methods for chronic pain 
(excluding headache) in adults found “small to moderate benefits, more for disability, mood and 
catastrophic thinking than for pain … in trials which compared CBT with no treatment”.41,65 The 2012 
review found too few studies that assessed health care use or work loss to include them. Since these are 
commonly invoked as ultimate goals of improving function and self-management,30,58 and of increasingly 
interest to third party funders,13,17 we believed that a systematic review was due to summarise the 
current evidence. 
In Europe,9  the US17 and elsewhere,7 people with chronic pain are frequent healthcare users. In the UK, 
primary care appointments for chronic pain cost £69 million56  and analgesic prescriptions cost £500 
million annually.13 Health care use may be evaluated in terms of numbers or extent of consultations, 
investigations and treatments, ideally from independent records rather than patient self-report, or as 
costs. Seeking and receiving health care are consistently predicted by psychological variables, such as 
anxiety, depression (e.g.3,31), and increased attention to pain,38 as well as by increased pain, so 
psychological interventions appropriately aim to reduce use of medical resources. Reduced health care 
use and costs following psychologically-based pain management have been reported in the USA58 and in 
the UK,11 but fall short of continued unnecessary and even harmful expenditure on further treatments 
for chronic pain.17 We therefore sought to investigate to what extent health care use reduced as a result 
of standard psychologically-based pain management.   
Chronic pain is also a major cause of loss of work days and of underperformance in the workplace,6,9 and 
thus of welfare payments to those unable to work.13 Although it has been proposed that the same 
psychological factors affect work absence and performance in chronic pain as affect other activities, in 
particular fear of pain or injury and avoidance of activities associated with those fears,54,63 a systematic 
review of work loss in people with chronic low back pain could find no clear predictors.32 The 2001 
systematic review by Guzmán et al.21 found little evidence that pain management reduced workdays lost 
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4 
in working participants, although ‘work readiness’ was reported to be improved in those not at work. On 
the other hand, return to work or starting work is a common goal during pain rehabilitation for many of 
working age. We hoped that more recent attention to work outcomes would provide sufficient data for 
meta-analysis. 
 
We therefore aimed to include in a systematic review and meta-analysis of psychological interventions 
for chronic pain any indicators of health care use and work loss. We drew from the studies in the 2012 
review by Williams et al.65 psychological treatments for chronic pain (excluding headache) in adults, 
compared with treatment as usual, waiting list control, or active treatment control); we updated 
searches using the same search terms and selection criteria, while relaxing the requirement for at least 
20 participants in any arm at the end of treatment to 10 (as in the 2009 systematic review15).  
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2. Methods 
2.1. Search strategy 
First, we searched the Eccleston et al.15 and Williams et al.65 reviews for any trials reporting health care 
use, work absence, or both, as outcomes. We then extended the searches for the 2012 review (which 
searched to September 2011) of the Cochrane Central Register of Controlled Trials (CENTRAL 2013), 
MEDLINE, EMBASE and PsychInfo, from January 201165 to January 2015. We made minor adjustments to 
search terms where required by changes in search systems. An example search strategy is given in 
online Appendix 1. No language restrictions were applied. We also updated our search of clinical trials 
registers and, as in the Williams et al. review, 65 we also searched the reference lists of retrieved papers.  
2.2. Inclusion and exclusion criteria 
As in the previous review, studies were included if they: 
- were available as a full publication or report of a randomized controlled trial; 
- had a design that placed a psychological treatment as an active treatment of primary interest. 
As in the Williams et al. 65 review, psychological treatment was deemed credible if it was based on 
an existing psychological model or framework, and its delivery was by, or was supervised by, a 
healthcare professional qualified in psychology; 
- had a psychological treatment with definable psychotherapeutic content, that is, based on an 
existing psychological model or framework, and delivered and/or supervised by a healthcare 
professional qualified in psychology; 
- had at least one trial arm consisting of a psychological intervention, with at least one 
comparator arm of an attention control, other active treatment, treatment as usual or waiting list 
control; 
- were published (or electronically pre-published) in a peer-reviewed scientific journal; 
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- were with participants (aged 18 years or older) reporting chronic pain (of at least three months’ 
duration) in any body site; 
- were not concerned with headache or associated with a malignant life-threatening disease; 
- had 10 or more participants in each treatment arm at the end of treatment (returning to 
previous criteria in Eccleston et al.15 to include previously excluded studies). 
In addition, we required that they measured health care use or costs, work absence or costs of work 
absence post-treatment, or a combination, as an outcome or outcomes. 
Given the diversity of possible indicators of health care use, any data were included that assessed post-
treatment use of health service resources, whether by self-referral, medical referral, or as part of a 
medical insurance package. Thus any visits or consultations by patients to or of doctors, physical 
therapists, nurse or other healthcare professionals were eligible, as were outpatient visits, hospital 
stays, or procedures, whether assessed by patient report or by independent records. In the latter case, it 
was not always clear that pain-related visits were distinguished from non-pain related visits but, since 
post-treatment data were compared across treatment and control groups, the assumption was made 
that any reduction in health care use after pain treatment would at least in part be related to a lesser 
use of health care for pain. We also collected data on medication use as an indicator of change in health 
status. We did not include use of complementary or alternative treatments, the costs of which were 
often borne by patients themselves.  
 
Work loss data included any measurement of sick leave or work absence, whether recorded as days or 
as episodes over a set time, and either from patient report or from insurance or work records. As with 
health care use, if these were expressed in terms of cost, they were included. 
Trials included in the previous systematic review and meta-analysis15, 65 were automatically included in 
this review if they reported health care use or work loss data. Studies in process at the time of the 
Williams et al.65 review were followed up for publications and, where data were missing, authors were 
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contacted. Of the 16 authors contacted, seven did not respond, five clarified that they had not 
measured either outcome, and four provided data.35,39,50,52 
2.3. Data extraction and management 
The authors independently extracted data and risk of bias from this final set of papers and achieved 
consensus where there was disagreement. Descriptive characteristics of participants and treatments, 
including setting and mode of delivery, and treatment data were collected.  
2.4. Risk of bias and quality rating 
Risk of bias was assessed according to Cochrane principles.23 Of the five suggested ’Risk of bias’ 
categories, random sequence generation (selection bias), allocation concealment (selection bias), 
blinding of outcome assessment (detection bias), incomplete outcome data (attrition bias), and selective 
reporting (reporting bias) were included. The option of ’blinding participants and personnel’ was 
excluded because neither therapists nor patients can be blinded to whether they deliver or receive 
treatment. As in the previous reviews,15,65 we used a quality rating scale specifically designed for 
psychological interventions in pain.68 This provided an overall total score (0 to 35) from two sub-scales: a 
treatment sub-scale (0 to 9), covering the stated rationale for treatment, manualization, therapist 
training and patient engagement; and a design and methods sub-scale (0 to 26), covering 
inclusion/exclusion criteria, attrition, sample description, minimization of bias (randomization method, 
allocation bias, blinding of assessment, equality of treatment expectations), selection of outcomes, 
length of follow-up, analyses and choice of control.  
The first four ’Risk of bias’ items from the Cochrane Handbook for Systematic Reviews of Interventions23 
are represented in the design section of the Yates et al. scale,68 accounting for up to five of the nine 
points available. Two authors (AP, AW) scored all studies and reached a consensus after initial 
comparisons or ratings.  
2.5. Meta-analysis of treatment effect 
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8 
All data were analyzed using RevMan5.3,48 the tool designed for the Cochrane Collaboration that 
calculates effect sizes and other indices in meta-analyses.12,23  Where continuous data were reported, 
treatment effects were estimated using standardized mean differences by extracting means, standard 
deviations and sample size, and using random (rather than fixed) effects, given the likely 
heterogeneity.23 Where data were dichotomous, treatment effects were estimated using odds ratios by 
extracting events data and sample sizes, again with random effects for the same reason, likely 
heterogeneity.  
Where a trial had more than one treatment arm, the arm designated as active treatment was either the 
most psychologically comprehensive or best matched the description of a psychological intervention. 
We aimed, if there were sufficient data, to carry out sub-analyses by treatment (cognitive behavioral 
versus behavioral) and by control group (active treatment versus waiting list or treatment as usual), as 
in Williams et al.65 We also planned to analyze post-treatment data separately from follow-up of three 
months or more, choosing the longer where there was more than one, up to 24 months. 
 
Between-trial heterogeneity is automatically calculated in RevMan and expressed using the I² statistic. I² 
values above 50% indicate high heterogeneity, between 25% and 50% medium heterogeneity, and 
below 25% low heterogeneity. Heterogeneity, which can be substantial despite using random effects 
models, should be regarded as an approximate estimate, rather than a point estimate, and although 
random effects allow for heterogeneity attributable to random error, but between-study heterogeneity 
assessed by I2 can indicate non-random sources.23   
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3. Results  
3.1. Search   
The search of previous systematic reviews identified 13 papers describing randomized controlled trials, 
nine from the 2012 Cochrane review2,19,26,27,29,34,50,66 and four from the earlier 2009 review (which 
permitted 10 ≤ N <20).16,28,37,40 The updated search found four new trials,35,39,52,60 and one follow-up of 
an earlier trial (10 follow-up26). One further trial59 was obtained from reference lists of other studies. This 
made 18 trials altogether (see Figure 1, study flow diagram), half of which were published in the last 10 
years. 
Figure 1 about here 
The excluded studies from the current search were rejected for the following reasons. Two were 
insufficiently psychological;20,62 two did not provide outcome data on health care use or work;36,45 one 
was not chronic pain;49 and one was an internet study.8 Details of studies excluded from the two 
previous reviews,15,65 with reasons for exclusion, are published in those reviews. 
 
3.2. Participants 
Studies were predominantly from Europe, with only two from the US.40,59 The 18 included trials 
comprising 2253 participants (74% female) at the start of treatment and 1932 at the end (means 125 
and 107 per study respectively): the mean completion rate was 86%. Table 1 shows the numbers of 
studies and participants in each analysis.  
Table 1 about here 
Most participants were between 35 and 60, with a mean of 46 years. Participants in four studies were all 
women (N = 373) and in the other 14 studies women usually outnumbered men, at a mean 69% (range 
2% - 98%). They were recruited from pain or other specialist clinics (10 studies), primary care (4 studies), 
community or volunteer sources (3 studies) and one from a work-related insurance register. Where 
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10 
duration of pain was reported, the mean was around 4 years but with a long upper tail to the 
distribution, including a report of 50-year pain duration.39 Seven studies recruited patients with mixed 
chronic pain, usually with a predominance of low back pain, and four recruited patients with low back 
and/or neck pain. One study was of patients with shoulder pain, one of temporomandibular disorder 
(TMD), and one with mixed low back pain and TMD. Four studies were of people with fibromyalgia.  
Fourteen studies tested cognitive and behavioral treatments (including Acceptance and Commitment 
Therapy (ACT) and Mindfulness-Based Stress Reduction (MBSR)) within a smaller or larger package of 
treatments, often including physical therapy; two tested behavioral therapies (one operant;16 one 
graded exposure;18 and one tested cognitive methods.35 Twelve studies had two arms, using as controls 
two non-enriched CBT interventions, four physical therapy interventions, five treatment as usual, and 
one waiting list. Five studies had three arms; three used a non-enriched CBT and waiting list as 
comparisons,40,50,66 one used a behavioral treatment and usual care,16 and one used physical therapy 
and usual care.60 The study with four arms used physical therapy, behavioral therapy, and usual care as 
comparisons. Whereas patients in the active control arm all received the same treatment, patients 
assigned to treatment as usual or waiting list (which usually does not preclude receiving treatment as 
usual) could experience anything from no healthcare contact to regular consultations or treatment 
sessions, and were rarely asked to report it.  
3.3. Health care use 
Fifteen studies assessed health care use at the end of treatment or at follow-up of various lengths. 
Where there was a choice, we used the latest endpoint for which data were provided for intervention 
and control groups. Table 1 shows the 13 studies that provided data either on health care consultations 
or resource use and/or on medication consumption or abstinence. The three Figures 2-4 comprise two 
concerning health care resource use other than medication, one with continuous data and the other 
with event-related data, and one concerning medication use, with event-related data.  
Table 2 about here 
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3.3.1. Consultations and resource use 
Nine studies provided means and standard deviations for standard mean differences in Figure 2, and 
four studies provided event-related data for Figure 3. Table 2 provides details for each study. Ways of 
assessing health care use varied from recording physician visits only to direct costs of health care, one of 
only two studies that provided data not collected by self-report. The direct costs included medication, 
which was also used alone in the medication analysis since the data could not be disaggregated. 
However, medication represented a similar proportion of total direct health care costs: 26% for the 
intervention group and 31% for the control group. Figure 2 summarises these nine studies. The overall 
effect showed moderate superiority of intervention over control in reduction of health care use:  SMD = 
-0.38 (95% CI -0.73 to -0.02); z = 2.09, p = 0.04. Heterogeneity was high, at 83%. 
Figures 2 and 3 about here 
Figure 3 summarises four studies that assessed health care use variously, from physician visits to any 
further treatment for pain. The odds ratio showed no significant difference between intervention and 
control groups: OR = 0.53 (95% CI 0.18 to 1.54), and z = 1.17, p = 0.24, with moderately high 
heterogeneity of 67%. 
Two studies assessed health care use but did not provide analysable data. Alaranta et al.2 reported 
similar percentage changes in treatment and control groups for doctor and outpatient visits at 1 year 
follow-up, but no test was reported. Lindell et al.34 reported no significant difference in decrease in 
healthcare practitioner visits at 18 month follow-up between intervention and control groups. 
3.3.2. Medication use 
Seven studies reported medication change, of which five produced analysable data, three as events, 
Figure 4, and two as means and standard deviations (no figure): see Table 2 for details of studies. 
Medication was variously measured, from numbers of analgesics or any medication taken to costs of 
medication, and at different post-treatment points.   
Figure 4 about here 
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The three studies in Figure 4 included 109 people in intervention groups and 98 in control groups. The 
odds ratio showed no significant difference between groups: OR = 0.21 (95% CI 0.04 to 1.28); z = 1.69, p 
= 0.09. Heterogeneity was very high at 85%. The two studies in the second medication analysis included 
146 participants in intervention groups and 129 in control groups. The effect size of difference between 
groups appeared of moderate size but was non-significant: SMD = -0.65 (95% CI -1.56 to 0.26); z = 1.39, 
p = 0.16, and heterogeneity was high at 88%. Data from both studies, reported as means and standard 
deviations, appeared to be substantially skewed, and it was not clear that parametric analysis of data in 
the studies was appropriate or interpretable, so this should be treated with caution. Risk of bias was 
mostly uncertain or high, casting further doubt on this analysis.  
For both medication analyses, risk of bias was on average uncertain, and design quality was only 15/26. 
One further study39 reported that few patients reduced medication and there was no significant 
difference between groups, but data were not available. 
 
3.4. Work loss  
Nine studies provided data on work loss, in metrics such as mean or number of hours or days absent 
from work on health grounds, early retirement on health grounds, and cost of work loss (for which days 
of work absence were multiplied by the standard minimum wage). Follow-up times also differed: see 
Table 3. 
Table 3 about here 
Four studies (Figure 5) reported mean days of work lost, at various time points. They produced a 
nonsignificant SMD of -0.35 (95% CI -1.09 to 0.39); z = 0.92, p > 0.1. Heterogeneity was 94%, largely due 
to a single study with a substantial SMD. One further study28 that provided apparently eligible data at 
one year follow-up was excluded from the analysis because the intervention and controls differed so 
substantially at baseline that interpretation of follow-up scores was not possible, although the authors 
reported that the intervention reduced sick leave. 
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Figure 5 about here 
Two studies reported non-return to work (Lindell2008) or early retirement (Jensen2005), with no 
significant difference between the groups: OR = 2.05 (95% CI 0.52 to 8.11); z = 1.02, p > 0.1. 
Heterogeneity was 84%. Two further studies2,29 reported the number of participants with work absence 
of more than 30 days at follow-up. There was no significant difference between groups: OR = 1.11 (95% 
CI 0.71 to 1.72); z = 0.45, p > 0.5. Heterogeneity was zero, but the risk of bias was mostly high, and 
design quality was 16/26. 
One further study (Jensen1997) assessed work but did not provide analyzable data; it reported 
improvements in sick leave at six month follow-up in both treatment and control groups (essentially 
very similar CBT programs). A second paper,10 a ten-year follow-up of Jensen et al.,26 also reported 
significant benefits of full rehabilitation over both controls in reduced sick leave and disability pensions. 
We decided that this was too long a period compared with other included studies to be combined with 
them.  
 
4. Discussion   
The predominance of European studies in this review was not surprising, since insurance-based funding 
in the US militates against conducting RCTs in this population. We would argue, however, that since the 
content and process of pain management programmes is largely similar in Western healthcare systems, 
so are the gains for patients in clinical pain management programs.41  
Fifteen studies of CBT for chronic pain assessed health care use, as consultations and treatments with a 
narrower or wider range of healthcare professionals, or as medication intake, or both, mainly by self-
report. Treatment aimed to reduce all aspects of health care use, consistent with self-management and 
overall better function, and there was evidence from continuous data, with a moderate effect size, of 
successful reduction in health care use; this came from nine of the 15 studies, with nearly 900 
participants. We did not analyse cost savings separately.19,35 There were no major methodological 
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threats to interpretation. The other analyses, of healthcare events measured categorically and of 
medication, showed no evidence of benefit of treatment, but were substantially smaller, as was the 
number of participants in each analysis. There is a small risk of missing studies, although building on 
previous searches helps to minimise this; we cannot estimate whether there is a serious risk of 
publication bias, but most of these trials had multiple outcomes, and our sample included several 
without the hypothesised improvement. Given that costs to health service funders and to patients 
themselves are often cited as one of the reasons to provide treatment, it is surprising that health care 
use is not a more universal outcome in studies.  
Our review produced more positive findings on reducing health care use than comparable reviews, both 
of consultations for chronic low back pain:  Hoffman et al.24 and Kamper et al.30  It may be that including 
treatments as well as consultations shows a greater effect of treatment, and is certainly an important 
element of cost. In a large scale community study in Portugal, Azevedo et al.3 found that nearly half the 
adults who reported moderately or severely disabling chronic pain, with a median duration of 10 years, 
had a high rate of diagnostic tests in the last 6 months, while 22% were receiving specialist medical care, 
and 81% attending family physicians for their pain. Further, 76% were taking pain-related medication. It 
is just such an extended – or repetitive – sequence of tests and consultations, with no adequate 
resolution (given that respondents had at least moderately disabling pain) that psychological treatments 
for pain aim to curtail, with individuals understanding the non-harmful nature of their pains and 
adopting a more autonomous approach. Given the good evidence of high levels of health care use in 
people with persistent pain7 and widespread specific health worries associated with persistent pain6 of 
the sort that drive health care use,55 cognitive and behavioral pain management interventions are well 
placed to address beliefs and associated emotions and behavior, and thereby reduce the substantial 
associated costs33 which produce very little benefit for patients.  
Neither of the two analyses of trials assessing medication showed significant reduction, though 
concerns about data quality and trial methodologies urge cautious interpretation of this negative 
finding. Again, this is a variable better assessed at follow-up than immediately after treatment, although 
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there are many ways of measuring it (none standard). Medication reduction (medication in the form of 
opioid analgesics, any analgesics, or any pain-related medication) is variably specified as an aim of 
treatment, despite widespread concerns in the pain literature about long-term opioid use,4,53 and 
despite the presence of well-qualified staff associated with CBT trials, and the suitability of goal-setting 
methods for medication use.46  
Nine studies on work loss, at various points of follow-up, contributed to three small meta-analyses with 
different metrics; none showed significant benefit of treatment over control group. The small number of 
trials in each analysis and methodological concerns urge cautious interpretation. By contrast with our 
findings, Kamper et al.30 in their systematic review of chronic low back pain confidently reported 
benefits for return to work of multidisciplinary rehabilitation compared with physical treatments in the 
medium to long term (median 12 months), although there was no such advantage over usual care. An 
earlier systematic review34 reported a moderate effect size for long-term return-to-work outcomes after 
multidisciplinary treatment, while a third found too few trials to analyse.22  
Return to work is a specific outcome of some CBT for pain management, but help to return may require 
individual patient intervention and negotiation with potential or actual employers. Studies of return to 
work1,31,32,64 suggest that specific beliefs about workplace resources, as well as broader psychological 
variables, contribute to prediction of return to work. Further, individual and societal factors may make it 
an inappropriate goal or unlikely outcome: work may not be an immediate or medium-term goal for 
people with adequate financial resources, or a goal at all for those over retirement age. Where patients 
are diverse in age and other demographics, they have very variable pathways back to valued activities, 
with some opting for further education, voluntary work, family care, or other activities. Further, adverse 
local or national socioeconomic conditions can make the probability of less skilled patients finding paid 
work very low.   
There are recommended methods for improving return to work, based both in evidence and in clinical 
experience.42,43,44,51,64,67 Some require substantial workplace commitment to reintegrating the person 
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with pain, unlikely to be forthcoming in some workplaces and economic conditions. Specific needs to 
facilitate return to work, as identified in acute low back pain,47 include workplace support, emotional 
help, or physical reactivation. If that is the case, generic psychologically-based pain management, 
involving only the person with pain and not the workplace, would not necessarily resolve the obstacles 
to return to work. The same points apply to the problem of “presenteeism”,64 presence at work but 
working at reduced efficiency because of pain. 
Some of the implications of this systematic review and meta-analysis are obvious. Despite the lack of 
standardized or recommended measures, data on health care use (including medication) and return to 
work are not difficult to collect, albeit more meaningful at follow-up than immediately after treatment. 
Patient self-report may provide more accurate data on medications used, while automatically-recorded 
prescription data are valuable but they do not, however, capture variation in adherence to prescribed 
use, use of over-the-counter medications or use of other non-prescribed medications. Nationally-
recorded or insurance data on sick leave appears to differ from patient report, with high specificity for 
work absence but variable sensitivity;61 ideally both are used. Both health care use and work return 
outcomes, where appropriate, can be more easily translated into cost savings than the usual outcomes 
of pain, mood, and disability, or even quality of life, and there is a need for more economic studies of 
pain management.56 
From the viewpoint of improving intervention and long term wellbeing, both reducing health care use, 
with its risks of over-treatment and undermining of patients’ own resources, and improving return to 
work, given its well-established health benefits,64 are worthwhile outcomes. We were disappointed not 
to find more eligible studies, but systematic review is intended to establish the current state of the 
evidence, whatever the size. From a research viewpoint, despite some good supporting evidence 
reviewed in this and in other systematic reviews for health care use and for return to work, both 
outcomes need further study. We endorse the statement by Kamper et al.30 that both are ‘key 
considerations’, while patients also rate work status, though not health care use, as an important 
outcome5. 
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Legends for tables and figures 
Table 1  Data summary for included studies 
Table 2 Details of 13 studies that provided data on health care consultations or resource use and/or on 
medication consumption or abstinence 
Table 3 Details of 10 studies that provided data on work loss due to pain. 
 
Figure 1 Study flow: PRISMA diagram 
Figure 2 Standard mean differences for health care use: nine studies and overall effect size 
Figure 3 Event data on health care use: four studies and overall odds ratio 
Figure 4 Event data for medication use: three studies and overall odds ratio 
Figure 5 Standard mean differences for work loss: four studies and overall effect size  
 
 
 
 
 
 1 
 2 
 3 
 4 
 5 
 6 
 7 
 8 
 9 
10 
11 
12 
13 
14 
15 
16 
17 
18 
19 
20 
21 
22 
23 
24 
25 
26 
27 
28 
29 
30 
31 
32 
33 
34 
35 
36 
37 
38 
39 
40 
41 
42 
43 
44 
45 
46 
47 
48 
49 
50 
51 
52 
53 
54 
55 
56 
57 
58 
59 
60 
61 
62 
63 
64 
65 
Figure 1 Study flow  
 
65 records identified from systematic 
reviews and reference lists 
 
1915 records identified through 
database searching 
1980 records screened 
 
1581 records excluded 
on title 
399 abstracts screened 
 
375 records excluded on 
abstract 
 
24 full-text studies read  
18 studies included;  
13 from previous 
reviews;  
5 from new search 
 
6 studies excluded: 
2 no eligible outcomes; 
2 not psychological; 
1 not chronic pain;  
1 internet study. 
14 studies included in 
meta-analyses 
 
 
 
 
 
 
 
 
 
 
 
 
 
4 studies yielded no 
useable data 
Figure 1
Figure 2    
 
 
 
 
 
 
 
 
 
Figure 2
Figure 3  
 
 
 
 
 
Figure 3
Figure 4   
 
 
 
 
Figure 4
Figure 5   
 
 
 
 
 
 
 
Figure 5
Table 1 
 Studies 
reporting 
outcome 
Studies providing data for 
analysis 
N in tx 
groups 
N in control 
groups 
Average risk of 
bias 
Average 
design score 
(Yates) 
Health care use: 
consultations and 
resource use 
13 9 visits, costs, fig. 2 
4 visits, treatments, fig. 3 
490 
151 
399 
153 
Low/ uncertain 17/26 
Health care use: 
medication 
7 3 medication reduction, fig. 4 
2 medication change 
109 
146 
  98 
129 
uncertain 15/26 
Work loss 9 4 work days lost: fig. 5 
2 non-return to work 
303 
110 
240 
110 
low 16/26 
Table
Table 2 
Study Intervention Control Health care use Figure 
Flor (1993)16  CBT  
[biofeedback
]  
Usual care Doctor visits at 2 year follow-up 2 
Jensen (2001)26 
(Follow-up: Jensen 
(2005)25 
CBT  
 
Usual care 
 (BT, physical 
therapy) 
Physician visits at 3 year follow-
up  
3 
Kaapa (2006)29 CBT Physical therapy Visits to healthcare 
professionals at 2 year follow-
up 
2 
Moore (1985)40 CBT (couple 
and 
individual) 
 Waiting list (not 
followed up) 
Outpatient visits at 3-7 month 
follow-up 
Medication use: discussed in 
text 
2 
Sleptsova (2014)52 
(data from author) 
CBT Physical therapy Doctor, hospital and physical 
therapist visits  
Medication 3 month follow-up 
2 
 
4 
Turk (1996)59 CBT Behavioral + 
counseling 
“Use of healthcare resources” 
at 6 months 
 Any analgesic use at  6 months 
3 
 
4 
Van Eijk-Hustings (2013)60  CBT 
[exercise] 
Usual care Contacts with medical 
specialists at 18 month follow-
up 
2 
 
Williams (1996)66 CBT 
(inpatient 
and 
outpatient) 
Waiting list “Any further treatments…for 
the pain” 
Pain-related medication use 
3 
 
4 
McCracken (2013)39  
(data from author) 
ACT Usual care Visits to primary care doctors  
 
2 
Schmidt (2011)50  
(data from author) 
MBSR 
 
Waiting list 
(relaxation, 
support, education) 
Ongoing healthcare use and 
medical visits at short term 
follow-up  
3 
 
Geraets (2006)19 BT Usual care Direct health care costs 2 
Thieme (2003)57 BT operant Physical therapy Doctor visits at 15 month 
follow-up 
Medication at 15 month follow-
up 
2 
 
- 
Luciano (2013)35 CT Usual care Direct costs (including 
medication) at 1 year follow-up 
Medication at 1 year follow-up 
2 
 
- 
 
 
  
 
Table 2
Table 3 
Study Intervention Control Work loss Figure 
Alaranta (1994)2 CBT Physical therapy All sick leave > 30 days at 3 
month follow-up 
- 
 
Jensen (2001)26 CBT  
 
Usual care  
[BT, physical 
therapy] 
Early retirement: 3 year follow-
up 
- 
 
Johansson (1998)28 CBT Waiting list Work absence % at 1 month 
follow-up 
5 
Kääpä (2006)29 CBT Physical therapy Work absence 2 year follow-up - 
Lindell (2008)34 CBT Usual care Non-return to work at 18 month 
follow-up 
- 
 
Marhold (2001)37 CBT Usual care Work absence 6 month follow-
up 
5 
Van Eijk-Hustings (2013)60  CBT 
 
usual care 
[exercise] 
Hours of work absence per week 
18 month follow-up 
- 
 
Geraets (2006)19 BT Usual care Sick days at 1 year follow-up 5 
Luciano (2013)35 CT Usual care Cost of work lost (= days x 
minimum daily wage) 
5 
 
Jensen (1997)27 Woman-
specific CBT 
Regular CBT Sick leave in excess of 14 days No 
usable 
data 
 
 
 
 
 
Table 3
Appendix 1: Sample Search Strategy 
(PsycINFO) 
1. exp pain/ 
2. (chronic* adj6 pain*).mp. 
3. 1 and 2 
4. (chronic* adj6 (discomfort or ache*)).mp. 
5. (chronic* adj6 (fibromyalgia or neuralgi* or dysmenorrhea or dysmennorrhoea)).ti,ab. 
6. 1 or 2 or 3 or 4 or 5 
7. exp Psychotherapy/ 
8. Cognitive Therapy/ 
9. exp Behavior Therapy/ 
10. Biofeedback/ 
11. ((behaviour* or cognitive) adj (therapy or therapies)).mp. 
12. (relax* adj6 (technique* or therapy or therapies)).mp. 
13. (meditat* or psychotherap*).mp. 
14. ((psychological or group) adj (treatment or therapy or therapies)).mp. 
15. (self-regulation adj training).mp. 
16. (coping adj skill*).mp. 
17. (pain-related adj thought*).mp. 
18. (behaviour* adj6 rehabilitat*).mp. 
19. ((psychoeducation or psycho-education) adj (group or groups)).mp. 
20. (mind and ((body adj relaxation) or (relaxation adj technique))).mp. 
21. exp dualism/ or exp relaxation/ or exp relaxation therapy/ 
22. 7 or 8 or 9 or 10 or 11 or 12 or 13 or 14 or 15 or 16 or 17 or 18 or 19 or 20 or 21 
23. 6 and 22 
24. (2007* or 2008* or 2009* or 2010* or 2011* or 2012* or 2013*).up. 
25. 23 and 24 
26. limit 25 to yr="2011 - 2013" 
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